Cogent Biosciences, Inc.
COGT NASDAQHealthcare ★★★★★Latest Earnings
Date
Aug 10, 2026
ET
EPS Est.
-0.56
EPS Actual
-0.52
Revenue Est.
$1000
Revenue Actual
--
Next Earnings Report Date unconfirmed
Date
Nov 6, 2026 · Fri
Time
Your time zone matches ET
Pre-market(ET)
Fiscal Period
FY2026 Q3
EPS Est.
-0.57
Revenue Est.
$750000
Company Overview
Cogent Biosciences, Inc. (ticker COGT) is listed on NASDAQ with a market cap of about $6.28B. Its next earnings report (FY2026 Q3) is expected on Nov 6, 2026 (ET), Pre-market (date pending company confirmation), with consensus EPS of -0.57. In the last 15 reported quarters, EPS beat consensus estimates 5 times.
Actual EPS TrendRecently15Term · Mar 14, 2023 → Aug 10, 2026
Mar 14, 2023Range: -0.64 ~ -0.50Aug 10, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 10, 2026 | -- | -0.56 | -0.52 | $1000 | -- |
| May 5, 2026 | -- | -0.53 | -0.53 | $500 | -- |
| Feb 17, 2026 | -- | -0.51 | -0.55 | $1.7M | -- |
| Nov 7, 2025 | -- | -0.54 | -0.50 | -- | -- |
| Aug 5, 2025 | -- | -0.55 | -0.53 | -- | -- |
| May 6, 2025 | -- | -0.56 | -0.52 | -- | -- |
| Feb 25, 2025 | -- | -0.59 | -0.61 | -- | -- |
| Nov 12, 2024 | -- | -0.55 | Below forecast↓-0.64 | -- | -- |
| Aug 6, 2024 | -- | -0.55 | -0.59 | -- | -- |
| May 7, 2024 | -- | -0.50 | Below forecast↓-0.62 | -- | -- |
| Feb 26, 2024 | -- | -0.54 | Below forecast↓-0.63 | -- | $5.6M |
| Nov 2, 2023 | -- | -0.50 | Below forecast↓-0.64 | -- | -- |
| Aug 8, 2023 | -- | -0.53 | -0.59 | -- | -- |
| May 9, 2023 | -- | -0.58 | -0.54 | -- | -- |
| Mar 14, 2023 | -- | -0.50 | -0.56 | -- | -- |
Original Filings (SEC)
Quarterly10-Q · 2026-08-10 ↗
Earnings Release8-K · 2026-08-10 ↗
Quarterly10-Q · 2026-05-05 ↗
Earnings Release8-K · 2026-05-05 ↗
Annual10-K · 2026-02-17 ↗
Earnings Release8-K · 2026-02-17 ↗
Quarterly10-Q · 2025-11-07 ↗
Quarterly10-Q · 2025-08-05 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
